Procept Biorobotics (PRCT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRCT Annual Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Procept Biorobotics manages its resources, obligations, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent245.64
Cash & Short-term Investments245.00
Accounts receivable96.39
Inventories77.54
Prepaid Expense And Other Assets Current8.47
Total Current Assets428.03
Equipment/Property/Plant Net31.74
Intangible Assets0.64
Other Assets, Noncurrent26.65
Restricted Cash Noncurrent3.04
Operating Lease Right Of Use Asset17.16
Total Assets487.06
Liabilities
Accounts Payable, Current AC18.85
Accrued Salaries, Current18.48
Derivative Liability, Current DE0.00
Other Liabilities, Current26.31
Total Current Liabilities63.64
Long-term debt51.66
Total Long-term Debt51.66
Other liabilities, Noncurrent24.10
Contract With Customer Liability Current13.70
Operating Lease Liability Noncurrent23.97
Total Liabilities139.40
Stockholders' Equity
Additional Paid In Capital Common Stock1,020.88
Retained Earnings / Accumulated Deficit-673.20
Other Equity-0.02
Common Stockholder's Equity347.67
Total Stockholder's Equity347.67
Liabilities & Stockholder's Equity487.06
4 historic quarters locked

Sign in to unlock the full Procept Biorobotics balance sheet history.

About Procept Biorobotics Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001588978-26-000030

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.